Abstract:Diverse Lactobacillus strains are widely used as probiotic cultures in the dairy and dietary supplement industries, and specific strains, such as Lactobacillus acidophilus NCFM, have been engineered for the development of biotherapeutics. To expand the Lactobacillus manipulation toolbox with enhanced efficiency and ease, we present here a CRISPR (clustered regularly interspaced palindromic repeats)-SpyCas9 D10A nickase (Cas9 N )-based system for programmable engineering of L. acidophilus NCFM, a model probiotic bacterium. Successful single-plasmid delivery system was achieved with the engineered pLbCas9 N vector harboring cas9 N under the regulation of a Lactobacillus promoter and a cloning region for a customized single guide RNA (sgRNA) and editing template. The functionality of the pLbCas9 N system was validated in NCFM with targeted chromosomal deletions ranging between 300 bp and 1.9 kb at various loci ( rafE , lacS , and ltaS ), yielding 35 to 100% mutant recovery rates. Genome analysis of the mutants confirmed precision and specificity of the pLbCas9 N system. To showcase the versatility of this system, we also inserted an mCherry fluorescent-protein gene downstream of the pgm gene to create a polycistronic transcript. The pLbCas9 N system was further deployed in other species to generate a concurrent single-base substitution and gene deletion in Lactobacillus gasseri ATCC 33323 and an in-frame gene deletion in Lactobacillus paracasei Lpc-37, highlighting the portability of the system in phylogenetically distant Lactobacillus species, where its targeting activity was not interfered with by endogenous CRISPR-Cas systems. Collectively, these editing outcomes illustrate the robustness and versatility of the pLbCas9 N system for genome manipulations in diverse lactobacilli and open new avenues for the engineering of health-promoting lactic acid bacteria. IMPORTANCE This work describes the development of a lactobacillus CRISPR-based editing system for genome manipulations in three Lactobacillus species belonging to the lactic acid bacteria (LAB), which are commonly known for their long history of use in food fermentations and as indigenous members of healthy microbiotas and for their emerging roles in human and animal commercial health-promoting applications. We exploited the established CRISPR-SpyCas9 nickase for flexible and precise genome editing applications in Lactobacillus acidophilus and further demonstrated the efficacy of this universal system in two distantly related Lactobacillus species. This versatile Cas9-based system facilitates genome engineering compared to conventional gene replacement systems and represents a valuable gene editing modality in species that do not possess native CRISPR-Cas systems. Overall, this portable tool contributes to expanding the genome editing toolbox of LAB for studying their health-promoting mechanisms and engineering of these beneficial microbes as next-generation vaccines and designer probiotics.

Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus

Efficient Genome Editing in <i>Bacillus licheniformis</i> Mediated by a Conditional CRISPR/Cas9 System

Portable CRISPR-Cas9N System for Flexible Genome Engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei

Gene Knockout of Bacillus licheniformis Mediated by CRISPR/Cas9 System

Repurposing the Endogenous CRISPR-Cas9 System for High-Efficiency Genome Editing in Lacticaseibacillus paracasei

Exploiting heterologous and endogenous CRISPR‐Cas systems for genome editing in the probiotic Clostridium butyricum

Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia

Harnessing the endogenous Type I-C CRISPR-Cas system for genome editing in Bifidobacterium breve

Genomic and epigenetic landscapes drive CRISPR-based genome editing in Bifidobacterium

High-Efficiency Genome Editing Based on Endogenous CRISPR-Cas System Enhances Cell Growth and Lactic Acid Production in Pediococcus acidilactici

Design and Construction of Portable CRISPR-Cpf1-Mediated Genome Editing in Bacillus subtilis 168 Oriented Toward Multiple Utilities

CRISPR–Cas-mediated gene editing in lactic acid bacteria

Transcription modulation of pathogenic streptococcal and enterococcal species using CRISPRi technology

Repurposing endogenous type II CRISPR-Cas9 system for genome editing in Streptococcus thermophilus

Using an Endogenous CRISPR-Cas System for Genome Editing in the Human Pathogen Clostridium difficile

CRISPR-Cas-Based Engineering of Probiotics

A Novel and Efficient Method for Bacteria Genome Editing Employing both CRISPR/Cas9 and an Antibiotic Resistance Cassette.

CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species

Development of Base Editors for Simultaneously Editing Multiple Loci in Lactococcus lactis

Bacterial genome editing by coupling Cre-lox and CRISPR-Cas9 systems

CRISPR/Cas9-Based Genome Editing for Protein Expression and Secretion in Kluyveromyces lactis